Inspire Medical Systems, INC Form 4 insider transactions

Director Casey M. Tansey acquired 103 shares of Inspire Medical Systems, Inc. common stock in lieu of cash fees on April 14, 2025, at a price of $149.7 per share.

Gary Lee Ellis, a director at Inspire Medical Systems, acquired 169 shares of common stock on April 14, 2025, in lieu of cash fees, according to a Form 4 filing.

Georgia Melenikiotou, a director of Inspire Medical Systems, acquired 102 shares of common stock on April 14, 2025, in lieu of cash fees.

Shelley G. Broader, a director at Inspire Medical Systems, acquired 116 shares of common stock on April 14, 2025, in lieu of cash fees.

Executive Vice President of Inspire Medical Systems, Randy Ban, sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

John Rondoni, Chief Technology Officer of Inspire Medical Systems, sold 2,287 shares of common stock on March 3, 2025, at a price of $185.6 per share.

CEO Timothy Herbert reports acquisition of shares through vesting and disposition of shares to cover tax obligations.

Bryan K. Phillips, a Senior Vice President at Inspire Medical Systems, reports the acquisition of shares from vested performance stock units and shares withheld for tax obligations.

John Rondoni, Chief Technology Officer of Inspire Medical Systems, reports the acquisition of 3,296 shares of common stock due to vesting of performance stock units and the disposal of 1,009 shares for tax obligations.

Richard Buchholz, CFO of Inspire Medical Systems, reports stock transactions including the disposal of shares to cover tax obligations and acquisition of shares through vesting of performance stock units.

Randy Ban, an executive at Inspire Medical Systems, reported the acquisition and disposal of company stock related to vesting performance stock units.

Jason P. Kelly, Chief Manufacturing and Quality Officer at Inspire Medical Systems, received 4,541 restricted stock units on February 13, 2025, vesting in three equal annual installments starting February 13, 2026.

Carlton Weatherby, Chief Strategy and Growth Officer at Inspire Medical Systems, reports the acquisition and disposal of company stock.

Richard Buchholz, CFO of Inspire Medical Systems, reports the acquisition and disposal of company stock, including tax withholding and an award of restricted stock units.

Bryan Phillips, a Senior Vice President at Inspire Medical Systems, reports the acquisition and disposal of company stock, including transactions related to tax withholding and restricted stock units.

Executive Vice President of Inspire Medical Systems, Randy Ban, reports the acquisition and disposal of company stock, including sales under a pre-arranged 10b5-1 trading plan.

Melissa Mann, Chief People Officer of Inspire Medical Systems, received 5,076 shares of common stock on February 13, 2025, as part of a restricted stock unit award.

John Rondoni, Chief Technology Officer of Inspire Medical Systems, received 5,076 restricted stock units on February 13, 2025, vesting in three equal annual installments starting February 13, 2026.

CEO Timothy Herbert reports stock transactions including tax withholding and an award of restricted stock units.

Chief Technology Officer of Inspire Medical Systems, John Rondoni, reports the disposition of shares to cover tax obligations and sales under a pre-arranged trading plan.

Gary Lee Ellis, a director at Inspire Medical Systems, acquired 137 shares of common stock in lieu of cash fees.

Shelley G. Broader, a director at Inspire Medical Systems, acquired 92 shares of common stock in lieu of cash fees.

Director Georgia Melenikiotou acquired 80 shares of Inspire Medical Systems common stock on January 15, 2025, in lieu of cash fees.

Casey M. Tansey, a director at Inspire Medical Systems, acquired 81 shares of common stock in lieu of cash fees on January 15, 2025.

John Rondoni, Chief Technology Officer of Inspire Medical Systems, sold 58 shares of common stock on January 7, 2025, at a price of $215 per share.

CEO Timothy P. Herbert transferred shares and options indirectly held through an LLC as part of estate planning transactions, ceasing to be the beneficial owner of those securities.

John Rondoni, Chief Technology Officer of Inspire Medical Systems, exercised stock options and sold shares on November 1, 2024, according to a Form 4 filing with the SEC.

Director Casey M. Tansey acquired 68 shares of Inspire Medical Systems, Inc. common stock in lieu of cash fees on October 14, 2024.

Georgia Melenikiotou, a director of Inspire Medical Systems, acquired 79 shares of common stock on October 14, 2024, in lieu of cash fees, according to a Form 4 filing with the SEC.

Director Gary Ellis of Inspire Medical Systems acquired 115 shares of common stock on October 14, 2024, in lieu of cash fees, according to a Form 4 filing.